SIK1 and osteoporosis: The role of SIK2 and 3 in bone formation has been recently investigated in osteocytes in which it has been demonstrated that SIK inhibitors in vitro can mimic the effect of parathyroid hormone (PTH), the only approved osteoporosis treatment that stimulates new bone formation.